Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension
Clinical trial NCT01365585 · COMPLETED
Trial details
- NCT number
- NCT01365585
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-07-01
- Primary completion
- 2011-10-01
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.